Zumla Alimuddin, Sahu Suvanand, Ditiu Lucica, Singh Urvasha, Park Young-Joon, Yeboah-Manu Dorothy, Osei-Wusu Stephen, Asogun Danny, Nyasulu Peter, Tembo John, Kapata Nathan, Alyaqoubi Fatma, Maani Amal Al, Blumberg Lucille, Zumla Adam, Ahmed Rizwan, Go Unyeong, Hui David S, Goletti Delia, Petersen Eskild
Department of Infection, Centre for Clinical Microbiology, Division of Infection and Immunity, University College London, London, United Kingdom; NIHR Biomedical Research Centre, UCL Hospitals NHS Foundation Trust, London, United Kingdom.
Stop TB Partnership Secretariat, Global Health Campus, Geneva, Switzerland.
IJID Reg. 2025 Mar 19;14(Suppl 2):100587. doi: 10.1016/j.ijregi.2025.100587. eCollection 2025 Mar.
•The WHO End TB strategy is stalling as shown in the Global Tuberculosis Report 2023.•The main reason is unequal access to tuberculosis diagnosis and treatment.•Tuberculosis diagnosis and treatment must be expanded outside urban centers down to the smallest and most remote unit.•Screening risk populations for latent tuberculosis will help identify infected persons before they develop active tuberculosis.
•如《2023年全球结核病报告》所示,世界卫生组织终止结核病战略正陷入停滞。
•主要原因是结核病诊断和治疗的可及性不平等。
•必须将结核病诊断和治疗扩展到城市中心以外,直至最小和最偏远的地区。
•对潜伏性结核感染的风险人群进行筛查,将有助于在感染者发展为活动性结核病之前识别出他们。